Literature DB >> 17719065

Beating and arrested intramyocardial injections are associated with significant mechanical loss: implications for cardiac cell transplantation.

Wes Hudson1, Maria C Collins, Dorian deFreitas, You S Sun, Barbara Muller-Borer, Alan P Kypson.   

Abstract

BACKGROUND: Cellular cardiomyoplasty is emerging as a potentially novel therapeutic option for heart failure and typically involves direct intramyocardial injection of donor cells into a beating heart. Yet, limited rates of cell engraftment remain an obstacle to be overcome before cell therapy is fully recognized. Mechanical and biological mechanisms may account for observed donor cell loss. This study examines acute mechanical loss during intramyocardial injections in beating and arrested hearts.
MATERIALS AND METHODS: A porcine cardiopulmonary bypass model was used. Animals underwent either beating (n = 5) or arrested (n = 5) intramyocardial injections into the left ventricle. Fluorescent microspheres were used in lieu of cells because they are biologically inert. Thirty minutes after delivery, animals were euthanized. Microspheres in cardiac and peripheral tissues were quantified using flow cytometry.
RESULTS: Approximately 10% of microspheres were retained within the site of injection in both groups. There was no statistical difference between microsphere retention rates in either the beating or the arrested heart group. Microspheres were found in peripheral organs, pericardial fluid, and the delivery device.
CONCLUSIONS: The majority of microspheres injected intramyocardially are lost in both beating and arrested hearts. Cardiac standstill does not enhance microsphere retention. Possible mechanisms include leakage from the injection site and washout via the cardiac venous/lymphatic system. Delivery strategy will need to be modified if more cells are to be retained within the target organ.

Entities:  

Mesh:

Year:  2007        PMID: 17719065     DOI: 10.1016/j.jss.2007.03.021

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  25 in total

Review 1.  Cell therapy for heart failure: a comprehensive overview of experimental and clinical studies, current challenges, and future directions.

Authors:  Santosh K Sanganalmath; Roberto Bolli
Journal:  Circ Res       Date:  2013-08-30       Impact factor: 17.367

Review 2.  Systems approaches to preventing transplanted cell death in cardiac repair.

Authors:  Thomas E Robey; Mark K Saiget; Hans Reinecke; Charles E Murry
Journal:  J Mol Cell Cardiol       Date:  2008-03-19       Impact factor: 5.000

Review 3.  Death and inflammation following somatic cell transplantation.

Authors:  Ian B Copland; Jacques Galipeau
Journal:  Semin Immunopathol       Date:  2011-05-01       Impact factor: 9.623

4.  Nanoparticles administered intrapericardially enhance payload myocardial distribution and retention.

Authors:  Victor Segura-Ibarra; Francisca E Cara; Suhong Wu; David A Iruegas-Nunez; Sufen Wang; Mauro Ferrari; Arturas Ziemys; Miguel Valderrabano; Elvin Blanco
Journal:  J Control Release       Date:  2017-07-09       Impact factor: 9.776

5.  Thermoresponsive hydrogel as a delivery scaffold for transfected rat mesenchymal stem cells.

Authors:  Bradley A Borden; James Yockman; Sung Wan Kim
Journal:  Mol Pharm       Date:  2010-08-02       Impact factor: 4.939

6.  Transplantation Effectiveness of Induced Pluripotent Stem Cells Is Improved by a Fibrinogen Biomatrix in an Experimental Model of Ischemic Heart Failure.

Authors:  Sebastian V Rojas; Andreas Martens; Robert Zweigerdt; Hassina Baraki; Christian Rathert; Natalie Schecker; Sara Rojas-Hernandez; Kristin Schwanke; Ulrich Martin; Axel Haverich; Ingo Kutschka
Journal:  Tissue Eng Part A       Date:  2015-07       Impact factor: 3.845

Review 7.  Stem cell therapy for cardiovascular disease: the demise of alchemy and rise of pharmacology.

Authors:  T Jadczyk; A Faulkner; P Madeddu
Journal:  Br J Pharmacol       Date:  2013-05       Impact factor: 8.739

8.  Cardiac cell therapy trials: chronic myocardial infarction and congestive heart failure.

Authors:  Philippe Menasché
Journal:  J Cardiovasc Transl Res       Date:  2008-03-14       Impact factor: 4.132

9.  Transplantation of multipotent Isl1+ cardiac progenitor cells preserves infarcted heart function in mice.

Authors:  Yunpeng Li; Shuo Tian; Ienglam Lei; Liu Liu; Peter Ma; Zhong Wang
Journal:  Am J Transl Res       Date:  2017-03-15       Impact factor: 4.060

Review 10.  Cell-based therapy for heart disease: a clinically oriented perspective.

Authors:  Philippe Menasche
Journal:  Mol Ther       Date:  2009-03-10       Impact factor: 11.454

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.